206 related articles for article (PubMed ID: 23722466)
1. Postoperative complications influence prognosis and recurrence patterns in periampullary cancer.
Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim YK
World J Surg; 2013 Sep; 37(9):2234-41. PubMed ID: 23722466
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
3. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.
van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ
Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
5. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.
Sohn TA; Lillemoe KD; Cameron JL; Huang JJ; Pitt HA; Yeo CJ
J Am Coll Surg; 1999 Jun; 188(6):658-66; discussion 666-9. PubMed ID: 10359359
[TBL] [Abstract][Full Text] [Related]
6. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.
Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373
[TBL] [Abstract][Full Text] [Related]
7. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
8. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
9. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.
Lillemoe KD; Cameron JL; Hardacre JM; Sohn TA; Sauter PK; Coleman J; Pitt HA; Yeo CJ
Ann Surg; 1999 Sep; 230(3):322-8; discussion 328-30. PubMed ID: 10493479
[TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
13. [Pancreaticoduodenectomy (Whipple's operation) for periampullary cancer].
Burcharth F; Andersen HB; Brahe NE; Baden H
Ugeskr Laeger; 1995 Oct; 157(40):5544-8. PubMed ID: 7571098
[TBL] [Abstract][Full Text] [Related]
14. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
15. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
16. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
[TBL] [Abstract][Full Text] [Related]
17. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
18. Underutilization of Surgery in Periampullary Cancer Treatment.
Michalski CW; Liu B; Heckler M; Roth S; Sun H; Heger U; Büchler MW; Hackert T
J Gastrointest Surg; 2019 May; 23(5):959-965. PubMed ID: 30088190
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD
Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
